- American Medical Association
- American Society of Clinical Oncology
- American Society of Hematology
Qian Qin, M.D.
- Eugene P. Frenkel, M.D. Scholar in Clinical Medicine
- Internal Medicine - Hematology/Oncology
- Bladder Cancer
- Kidney Cancer
New Patient Appointment Accepting Virtual Visits or 214-645-4673
Biography
Qian Qin, M.D., is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center. She specializes in bladder, kidney, prostate, and testicular cancer.
Dr. Qin earned her medical degree at Baylor College of Medicine. She completed her residency in internal medicine at Houston Methodist Hospital and gained advanced training through a hematology and medical oncology fellowship at the Icahn School of Medicine at Mount Sinai.
Certified by the Board of Internal Medicine, she joined the UT Southwestern faculty in 2021.
Dr. Qin is a member of the American Medical Association and the American Society of Clinical Oncology. She has published numerous academic articles and delivered several presentations.
Education & Training
- Internship - Houston Methodist Hospital (2015-2016)
- Fellowship - Icahn School of Medicine at Mount Sinai (2018-2021), Hematology Oncology
- Residency - Houston Methodist Hospital (2015-2018), Internal Medicine
- Medical School - Baylor College of Medicine (2011-2015)
Professional Associations & Affiliations
Books & Publications
-
Publications
-
Targeting HIF-2α in Renal Cell Carcinoma: Expanding upon Belzutifan.
Rodriguez M, Qin Q, Tambar U, Brugarolas J. Cancer 2026 -
A Review of Neoadjuvant Therapy for Localized and Locally Advanced Renal Cell Carcinoma
Qin Q, Tachibana I, Margulis V, Caddedu JA, Zhang T. Cancers 2025 -
A phase II study of niraparib (N), abiraterone acetate (AA) plus prednisone (P) for Hispanic/Latino (HL) and non-Hispanic Black (NHB) patients with metastatic hormone sensitive prostate cancer (mHSPC) and deleterious homologous recombination repair alterations (HRRa; HARMONY)
Qin Q, Jiang C, Song Zhang, Cole S, Courtney KD, Wang J, Arafat W, Vento J, Tawagi K, Reizine NM, Bilusic M, McGuire M, Rowell A, Wise DR, Reimers MA, Heath EI, Zhang T. ASCO Annual Meeting 2025 -
EXPLORE-RCC: a phase II study of neoadjuvant zanzalintinib (ZANZA) plus nivolumab (NIVO) in patients with locally advanced and/or inoperable clear cell renal cell carcinoma (ccRCC)
Q. Qin, S. Zhang, J. Brugarolas, H. Hammers, C. Jiang, J. Vento, K. Courtney, S. Cole, M. McGuire, E. Hasanov, E.A. Singer, D.M. Geynisman, A. Kutikov, M.A. Reimers, K. Gaston, I. Tachibana, V. Margulis, J. Cadeddu, T. Zhang. ESMO Annual meeting 2025 -
Systemic Treatment of Locally Advanced or Metastatic Non-Clear Cell.
Qin Q, Nein E, Flaten A, Zhang T. Cancers 2025 -
Durable Benefit from PARP Inhibitors in Metastatic Prostate Cancer in Routine Practice: Biomarker Associations and Implications for Optimal Clinical NGS Testing
Triner D, Graf R, Madison R, Gjoerup O, Tukachinsky H, Ross J, Quintanilha J, Li G, Cheng H, Pritchard C, Zurita A, Qin Q, Zhang T, Agarwal N, Reichert Z, Mateo J, Cieslik M, and Morgan T. 2024 -
Phase 2 trial for sequential treatment after cabozantinib progression in metastatic renal cell carcinoma [Seq-Cabo]
Qin Q, Hammers H, Brugarolas J, Arafat W, Courtney K, Zhang S, Cowey L, Hutson T, Zhang T. ASCO Annual Meeting 2024 -
Toxicity Management of Systemic Kidney Cancer Therapies.
Qian Qin, Ellen Nein, Andrea Flaten, Tian Zhang. Hematol Oncol Clin North Am 2023 -
Development of a novel HIF2a PET tracer: from proof of concept to a clinical trial.
Debnath S, Stevens C, Brandenburg O, Sovich J, Gonzalez P, Qin Q, Haldeman S, Tcheuyap VT, Christie A, Thapa P, Zhou N, Mulgoonkar A, Hoo G, Miyata J, Carrillo D, Cadeddu J, Kapur P, Anderson J, Pedrosa I, Dakanali M, Oz O, Sun X, Brugarolas J. AACR Annual Meeting 2022 -
PD-L1 PET: A potential biomarker of checkpoint inhibitor sensitivity in renal cancer.
Mulgoonkar A, Woolford L, Elias R, Guan KN, Hoo G, Stevens C, Tcheuyop VT, Haldeman S, Miyota J, Carrillo D, Qin Q, Singla N, Bowman I, Cadeddu J, Margulis V, Christie A, Kapur P, Pedrosa I, Dakanali M, Oz O, Sun X, Brugarolas J. AACR Annual Meeting 2022 -
Care disruptions among patients with lung cancer: A COVID-19 and cancer outcomes study.
Bhalla S, Bakouny Z, Schmidt AL, Labaki C, Steinharter JA, Tremblay DA, Awad MM, Kessler AJ, Haddad RI, Evans M, Busser F, Wotman M, Curran CR, Zimmerman BS, Bouchard G, Jun T, Nuzzo PV, Qin Q, Hirsch L, Feld J, Kelleher KM, Seidman D, Huang HH, Anderson-Keightly HM, El Zarif T, Abou Alaiwi S, Rosenbloom TD, Stewart PS, Galsky MD, Choueiri TK, Doroshow DB, Lung cancer (Amsterdam, Netherlands) 2021 Jul 160 78-83 -
Characterizing Prostate-Specific Antigen Levels at Death in Patients with Metastatic Castration-Resistant Prostate Cancer: Are We Underutilizing Imaging?
Bikkasani K, Qin Q, Zhong X, Lin J, Galsky MD, Oh WK, Tsao CK, Clinical genitourinary cancer 2021 Apr -
Risk Factors for Emergency Room and Hospital Care Among Patients With Solid Tumors on Immune Checkpoint Inhibitor Therapy.
Parikh AB, Zhong X, Mellgard G, Qin Q, Patel VG, Wang B, Alerasool P, Garcia P, Leiter A, Gallagher EJ, Clinton S, Mortazavi A, Monk P, Folefac E, Yin M, Yang Y, Galsky M, Oh WK, Tsao CK, American journal of clinical oncology 2021 03 44 3 114-120 -
Admission D-dimer levels, D-dimer trends, and outcomes in COVID-19.
Naymagon L, Zubizarreta N, Feld J, van Gerwen M, Alsen M, Thibaud S, Kessler A, Venugopal S, Makki I, Qin Q, Dharmapuri S, Jun T, Bhalla S, Berwick S, Christian K, Mascarenhas J, Dembitzer F, Moshier E, Tremblay D, Thrombosis research 2020 12 196 99-105 -
Cancer Care Disparities during the COVID-19 Pandemic: COVID-19 and Cancer Outcomes Study.
Schmidt AL, Bakouny Z, Bhalla S, Steinharter JA, Tremblay DA, Awad MM, Kessler AJ, Haddad RI, Evans M, Busser F, Wotman M, Curran CR, Zimmerman BS, Bouchard G, Jun T, Nuzzo PV, Qin Q, Hirsch L, Feld J, Kelleher KM, Seidman D, Huang HH, Anderson-Keightly HM, Abou Alaiwi S, Rosenbloom TD, Stewart PS, Galsky MD, Choueiri TK, Doroshow DB, Cancer cell 2020 Dec 38 6 769-770 -
Impact of anticoagulation prior to COVID-19 infection: a propensity score-matched cohort study.
Tremblay D, van Gerwen M, Alsen M, Thibaud S, Kessler A, Venugopal S, Makki I, Qin Q, Dharmapuri S, Jun T, Bhalla S, Berwick S, Feld J, Mascarenhas J, Troy K, Cromwell C, Dunn A, Oh WK, Naymagon L, Blood 2020 Jul 136 1 144-147 -
Urothelial carcinoma: the development of FGFR inhibitors in combination with immune checkpoint inhibitors.
Qin Q, Patel V, Galsky MD, Expert review of anticancer therapy 2020 06 20 6 503-512 -
Complete Local and Abscopal Responses from a Combination of Radiation and Nivolumab in Refractory Hodgkin's Lymphoma.
Qin Q, Nan X, Miller T, Fisher R, Teh B, Pandita S, Farach AM, Pingali SR, Pandita RK, Butler EB, Pandita TK, Iyer SP Radiation research 2018 Jun -
Leukapheresis reduces 4-week mortality in acute myeloid leukemia patients with hyperleukocytosis - a retrospective study from a tertiary center.
Nan X, Qin Q, Gentille C, Ensor J, Leveque C, Pingali SR, Phan AT, Rice L, Iyer S Leukemia & lymphoma 2017 Jan 1-11 -
Normal and disease-related biological functions of Twist1 and underlying molecular mechanisms.
Qin Q, Xu Y, He T, Qin C, Xu J, Cell research 2012 Jan 22 1 90-106
-
Targeting HIF-2α in Renal Cell Carcinoma: Expanding upon Belzutifan.
Research
- Investigator-Initiated Clinical Trials in Genitourinary Oncology
- Industry- and Cooperative Group-Sponsored Trials in Genitourinary Oncology
- Novel Biomarkers, Therapeutics, and Therapeutic Combinations in Genitourinary Oncology
Clinical Focus
- Bladder Cancer
- Kidney Cancer
- Prostate Cancer
- Testicular Cancer
Results: 1 Locations
Genitourinary Cancer Clinic
at Cancer Care Outpatient Building 6202 Harry Hines Blvd., 9th FloorDallas, Texas 75235 (214) 645-4673 Directions to Genitourinary Cancer Clinic at Cancer Care Outpatient Building, Dallas Parking Info for Genitourinary Cancer Clinic
New Patient Appointment Accepting Virtual Visits or 214-645-4673